Sort   by:  
 Page size 
UnknownQuantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia.
Not available
S-EPMC3397783 | biostudies-literature
TranscriptomicsTranscription profiling by array of acute myeloid leukemia patient samples for analysis of KIT and SP1 expression
Oligonucleotide expression microarray data used for analysis of KIT and SP1 expression levels in AML patient samples
ORGANISM(S): Homo sapiens 
2011-03-16 | E-TABM-945 | biostudies-arrayexpress
MetabolomicsNMR-based metabolomics identifies patients at high risk of death within two years after acute myocardial infarction in the AMI-Florence II cohort
Risk stratification and management of acute myocardial infarction patients continue to be challenging despite considerable efforts made in the last decades by many clinicians and researchers. The aim of this study was to investigate the metabolomic fingerprint of acute myocardial infarction using nu...
2018-10-02 | MTBLS395 | MetaboLights
UnknownClinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665.
Not available
S-EPMC5008253 | biostudies-literature
UnknownExcessive Accumulation of Ca2 + in Mitochondria of Y522S-RYR1 Knock-in Mice: A Link Between Leak From the Sarcoplasmic Reticulum and Altered Redox State.
Not available
S-EPMC6755340 | biostudies-literature
UnknownHigh Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.
Not available
S-EPMC5455698 | biostudies-literature
UnknownBortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502.
Not available
S-EPMC3577952 | biostudies-literature
TranscriptomicsGene expression signature associated with ASXL1 mutations in cytogenetically normal acute myeloid leukemia (CN-AML)
We studied gene expression profiles from 65 patients with CN-AML, who all had wild-type NPM1 and no FLT3-ITD. We identified an ASXL1 mutation-associated gene expression signature by comparing 26 ASXL1-mutated and 39 ASXL1-wild type patients. Only NPM1 wild type/FLT3-ITD-negative patients were includ...
ORGANISM(S): Homo sapiens 
2012-10-10 | E-TABM-1208 | biostudies-arrayexpress
UnknownFrequency of postoperative cognitive dysfunction after non-cardiac surgery and its impact on functional outcomes: protocol for a systematic review.
Not available
S-EPMC10510893 | biostudies-literature
UnknownMolecular prognostic factors in cytogenetically normal acute myeloid leukemia.
Not available
S-EPMC3582378 | biostudies-literature
Sort   by:  
 Page size